tiprankstipranks
Trending News
More News >
Hisamitsu Pharmaceutical Co Inc (HTSUF)
OTHER OTC:HTSUF
US Market

Hisamitsu Pharmaceutical Co (HTSUF) Income Statement

Compare
5 Followers

Hisamitsu Pharmaceutical Co Income Statement

Last quarter (Q3 2024), Hisamitsu Pharmaceutical Co's total revenue was ¥35.80B, a decrease of -0.15% from the same quarter last year. In Q3, Hisamitsu Pharmaceutical Co's net income was ¥4.56B. See Hisamitsu Pharmaceutical Co’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25Mar 24Mar 23Mar 22Mar 21
Total Revenue
¥ 156.01B¥ 141.71B¥ 128.33B¥ 120.19B¥ 114.51B
Gross Profit
¥ 91.20B¥ 78.97B¥ 72.70B¥ 70.07B¥ 69.17B
Operating Expenses
¥ 72.30B¥ 65.80B¥ 61.10B¥ 60.73B¥ 58.50B
Depreciation and Amortization
¥ 6.33B¥ 5.17B¥ 4.95B¥ 4.32B¥ 4.08B
EBITDA
¥ 35.05B¥ 24.37B¥ 16.55B¥ 13.66B¥ 14.75B
Operating Income
¥ 18.90B¥ 13.17B¥ 11.60B¥ 9.34B¥ 10.67B
Other Income/Expenses
¥ 9.79B¥ 6.02B¥ 4.51B¥ 3.62B¥ 1.53B
Pretax Income
¥ 28.69B¥ 19.19B¥ 16.11B¥ 12.96B¥ 12.20B
Net Income
¥ 21.76B¥ 13.97B¥ 11.74B¥ 9.66B¥ 9.25B
Per Share Metrics
Basic EPS
¥ 295.58¥ 181.61¥ 148.00¥ 118.92¥ 113.21
Diluted EPS
¥ 295.15¥ 181.41¥ 147.87¥ 118.84¥ 113.10
Weighted Average Shares Outstanding
73.61M 76.92M 79.34M 81.21M 81.71M
Weighted Average Shares Outstanding (Diluted)
73.72M 77.00M 79.41M 81.27M 81.79M
Currency in JPY

Hisamitsu Pharmaceutical Co Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis